Introduction
Niemann-Pick Type C (NPC) disease is a fatal, neurodegenerative disorder, caused by mutations in NPC1 or NPC2 1, 2 . NPC1 is a late endosomal transmembrane protein with a sterol-sensing domain homologous to the cholesterol sensor SCAP (sterol regulatory element binding protein (SREBP)-cleavage activating protein) 3, 4 ; NPC2 is a small lumenal protein in late endosomes/lysosomes 5, 6 . Both NPC1 and NPC2 can bind cholesterol [5] [6] [7] [8] , NPC1 also has affinity for oxysterols 9 . All NPC1-deficient cells accumulate cholesterol in late endosomal multivesicular bodies, and have an impaired homeostatic response of the SREBP pathway to exogenous cholesterol 10 . Based on these observations, it was proposed that NPC1 acts as a cholesterol sensor or transporter, and is required for cholesterol egress from endosomes to plasma membrane and to the regulatory pool in the endoplasmic reticulum 7, 10 . NPC1-deficient cells also sequester a variety of other lipids in their endosomes 11, 12 , and the possibility remains that cholesterol accumulation is not the primary defect. The exact function of NPC1 and how its loss leads to the observed neuropathology remain unknown.
Regardless of the primary storage material in NPC1-deficient endosomes, the sequestration of cholesterol has a widespread impact on cellular cholesterol distribution. Recently, it has been proposed that changes in mitochondrial cholesterol contribute to NPC pathology 13 . Cholesterol is required as a precursor for steroid and oxysterol synthesis at the mitochondrial inner membrane and as a component of mitochondrial membranes. Increased mitochondrial cholesterol can lead to mitochondrial dysfunction, including reduced fluidity of mitochondrial membranes 14, 15 , reduced ATP generation 16 , and decreased mitochondrial glutathione import 15 .
In line with the theory that cholesterol entrapment in NPC1-deficient endosomes limits its availability to the rest of the cell, it was found that steroid and oxysterol levels were decreased in NPC1deficient murine brain and fibroblasts [17] [18] [19] [20] [21] [22] . In seeming contradiction, several groups have reported increased cholesterol in mitochondria isolated from brain or liver of NPC1-deficient mice 15, 16, 23 .
The mechanisms by which cholesterol is transported to the mitochondrial outer and inner membranes under basal conditions are not well defined. In steroidogenic cells, cholesterol transport to the by guest, on August 15, 2017 www.jlr.org Downloaded from mitochondrial inner membrane, which is rate-limiting for steroid synthesis, is mediated by the steroidogenic acute regulatory (StAR) protein in conjunction with the translocator protein (formerly known as peripheral benzodiazepine receptor) 24, 25 . However, StAR-mediated transport is low under basal, non-stimulated conditions, and in non-steroidogenic cells, which do not express significant amounts of StAR. Since even under these conditions, cholesterol is needed for the upkeep of mitochondrial membranes and in some cases for oxysterol synthesis, other mechanisms of mitochondrial cholesterol import must exist. Recently, it was proposed that plasma membrane cholesterol transported via cytosolic transport proteins served as a source for mitochondrial oxysterol production 26 , but the mechanism was not defined in detail. Other potential mediators of mitochondrial cholesterol import include proteins that contain a lipid-binding domain homologous to the C-terminus of StAR (START proteins 27 ). Among these, endosomal MLN64 is of particular interest, since its START domain binds cholesterol and it has been shown to transport cholesterol to mitochondria when expressed as a soluble protein lacking the transmembrane N-terminus of MLN64 [28] [29] [30] .
In view of the strong link between mitochondrial cholesterol and mitochondrial function, and the central role of mitochondria in neurodegenerative disease 31 , this study was designed to elucidate mechanisms of basal mitochondrial cholesterol import in wildtype and NPC1-deficient cells. We show that mitochondrial cholesterol import does not require functional NPC1, and that MLN64 can mediate cholesterol transport from endosomes to mitochondria under basal conditions, its contribution likely depending on the relative availability of cholesterol from different pools. Furthermore, our data indicates that in NPC1-deficient cells, transfer of cholesterol from outer to inner mitochondrial membrane may become rate-limiting, leading to cholesterol build-up in mitochondrial outer membranes.
Materials and Methods

Materials
Cell culture media, FBS, and supplements were obtained from Invitrogen. Geneticin was from Wisent Inc. Trilostane and 22R-hydroxycholesterol (22-OH chol) were purchased from Steraloids. The by guest, on August 15, 2017 www.jlr.org Downloaded from rabbit anti-pregnenolone antibody was purchased from MP Biologicals. Charcoal-coated dextran, filipin complex III, and mouse anti-tubulin antibodies were purchased from Sigma. Rabbit anti-human NPC1 antibodies that fully crossreact with NPC1 from mouse and hamster were obtained from Novus Biologicals. MLN64 antibodies were from Affinity Bioreagents or Abcam, goat anti-actin and rabbit antimouse Tom20 antibodies were from Santa Cruz Biotechnologies, mouse anti-protein disulphide isomerase (PDI) was from Assay Designs. Rabbit antibodies directed against the voltage-dependent anion channel (VDAC) or against lysosome associated membrane protein (LAMP1), which crossreact with hamster VDAC or LAMP1, and rabbit anti-ferredoxin reductase antibodies were obtained from Abcam. Monoclonal colonies were selected for their survival in 500 µg/ml geneticin following serial dilution.
Cells were cultured in Ham's F12 medium containing 5% FBS, antibiotics, and 300 µg/ml geneticin to keep the cells under selection pressure. Hereafter, cells stably expressing the F2-fusion protein will be designated with the prefix "F2". Expression of F2-fusion complex was measured by RT-PCR. Total RNA was extracted from F2-cells using Trizol, then reverse transcribed using Superscript II (Invitrogen), cDNA was amplified using primers directed against cyclophilin and F2 (cyclophilin forward: 5'-TCT TCT TGC TGG TCT TGC CAT TCC-3', reverse: 5'-TCC AAA GAC AGC AGA AAA CTT TCG-3'; F2 forward (P450scc): 5'-AGT GGC CAT CTA TGC TCT GG-3': reverse (ferredoxin reductase): 5'-ATG TCC GTT CTC TCC AGG TG-3'). PCR products and DNA size standards (Fermentas) were separated on a 1.5% agarose gel and visualized with GelRed (Biotium).
In vitro CYP11A1 activity assay in lysed cells and subfractions
Cells were harvested into PBS, and homogenized in 1 ml ice-cold mitochondria isolation (MI) buffer (5 mM Hepes, 250 mM mannitol, 1 mM EGTA, 70 mM sucrose, pH 7.4, protease inhibitors) with 30 strokes in a Dounce homogenizer. Cell homogenates were centrifuged at 800 g, 4°C for 5 min to remove nuclei and unbroken cells, followed by centrifugation of the supernatant at 12,000 g, 4°C for 15 min to yield crude mitochondria. Samples were used immediately or frozen at -20°C for not longer than one week. CYP11A1 activity was determined essentially as described 37 . Cell homogenates, crude mitochondria or the 12,000 g supernatant were incubated for 1 h at 37°C in reaction buffer (250 mM sucrose, 20 mM KCl, 15 mM Tris-EDTA-HCl, 10 mM KH 2 PO 4 , 5 mM MgCl 2 , pH 7.2) with 2 mM NADPH, 2 mM malate/pyruvate, 5 µM 22R-OH-Chol, 0.3% Tween and an NADPH regenerating system (BD Biosciences). Trilostane (10 µM) was added during all incubations for pregnenolone measurement to 7 inhibit conversion of pregnenolone to downstream steroids 38 . Reaction mixtures were assayed for pregnenolone by radioimmunoassay (RIA) according to the protocol provided by MP Biologicals.
Measurement of cholesterol transport to the mitochondrial inner membrane
Cells were plated at a density of 200 cells/mm 2 , and grown for 48 h in growth medium. Cells were then washed twice in phenol red-free, serum-free Ham's F12/DMEM (1:1, v/v) (import medium) and incubated for 6 h or 24 h in import medium containing 10 µM trilostane. In experiments to determine the maximum rate of pregnenolone formation, 5 µM 22-OH-Chol was added to the import medium. Import medium was collected for measurement of pregnenolone by radioimmunoassay (RIA). Each assay included a standard curve of known amounts of pregnenolone, and a positive control of import medium with trilostane spiked with 300 pg pregnenolone to test recovery. A negative control of import medium (containing trilostane) that was not incubated with cells was routinely included, but did not give readings above background. Where indicated, cells were incubated for 48 h in Ham's F12 medium containing 5% LPDS with or without 50 µg/ml LDL, then washed and incubated for 24 h in import medium with 10 µM trilostane with or without 50 µg/ml LDL. Import medium and cells were collected and analyzed as above.
Immunolocalization of the F2 fusion complex
CHO cells grown on coverslips were transiently transfected with F2-pcDNA3.1 vector by electroporation. Two days after transfection, cells were incubated with 50 nM Mitotracker Red CMXRos (Invitrogen) according to manufacturer's protocol, then washed and fixed with 4% paraformaldehyde.
Cells were permeabilized with 0.1% Triton X-100 for 5 min, blocked with 1% BSA in PBS followed by sequential incubation with anti-ferredoxin reductase antibody (1:100) and Cy2-conjugated affinitypurified donkey anti-rabbit IgG (Jackson Immunoresearch). Images were acquired on a Nikon TE2000 epifluorescence microscope equipped with a CCD camera (Orca-AG, Hamamatsu) at filter settings of 474/23 nm and 585/29 nm (excitation), dual band dichroic, and 572/42 nm and 645/49 nm (emission), using a 60x oil immersion objective. Using these conditions, mitotracker staining alone did not yield measurable fluorescence in the green channel. 
Filipin staining
Cells grown on glass coverslips were fixed and stained with 50 µg/ml filipin as described 39 .
Images were acquired on a Nikon TE2000 epifluorescence microscope with CCD camera at filter settings of 387/11 nm (excitation) and 447/60 nm (emission), using a 20x objective.
Measurement of cholesterol biosynthesis
Cells were incubated for 48 h in Ham's F12 medium containing 5% LPDS, with or without 50 µg/ml LDL, washed twice in import medium and incubated for 24 h in import medium containing 1 µCi/ml [ 14 C]acetate, with or without 50 µg/ml LDL. Cellular lipids were extracted and separated by TLC with the solvent phase cyclohexane/ethyl acetate (3:2, v/v) 39 . Radioactivity was determined in the band corresponding to unesterified cholesterol by liquid scintillation counting.
RNA interference
Transfection with short interfering RNA (siRNA) was performed according to manufacturer's protocol using DharmaFECT 4 (Dharmacon). siRNA (Dharmacon) were added to the cells at a final concentration of 50 nM for siNT or siMLN64, or 25 nM each for transfection with a mixture of three siRNA against NPC1, using DharmaFECT 4 at a final concentration of 1:250 (v/v). The cells were grown with the siRNA for 24 h, then medium was replaced with growth medium for 24 h, before import medium with trilostane was added for 24 hours. Pregnenolone formation was measured by RIA. siRNA sequences were as follows: hamster NPC1: NPC1-1, sense 5'-GGAAAGAGUUCAUGAAAUUUU-3', antisense 5'-
, siGENOME duplex (1), D-048833-01; siGENOME duplex (3), D-048833-03; non-targeting siRNA: siCONTROL non-targeting siRNA #1, D-001210-01-05. The MLN64 siGENOME sequences were predesigned against mouse MLN64, sequences 1 and 3 were effective against hamster MLN64. The degree of protein depletion was tested by immunoblotting.
Isolation of mitochondria from cells and measurement of cholesterol content
Cells were harvested into PBS, collected by centrifugation, resuspended in 5 ml ice-cold MI buffer and ruptured by nitrogen cavitation 40 (1500 psi, 11 min on ice, cell disruption bomb 4639, Parr Instrument Company). Unbroken cells were removed by centrifugation at 800 g, 4°C, 10 min.
Centrifugation of the supernatant for 15 min, 4°C at 12,000 g yielded a crude mitochondrial fraction.
Where indicated, crude mitochondria were treated with 0.1% trypsin (T9935, Sigma) for 10 min at room temperature, then soybean trypsin inhibitor (Sigma) was added at 0.5 mg/ml. Crude mitochondria were resuspended in 250 µl MI buffer and overlaid on a step gradient of 50, 22.5, and 10% Percoll in MI buffer 40 . The gradients were centrifuged for 20 min, 4°C at 35,000 g in an SW61 rotor (Beckman). The mitochondria band was collected from the 50/22.5% Percoll interface, diluted 20-fold with MI buffer and centrifuged at 12,000 g, 4°C for 15 min to yield purified mitochondria 40 . A band visible at lower densities of the Percoll gradient was collected as an endosome/lysosome enriched fraction. Cholesterol was measured with the Amplex Red assay (Invitrogen) without the addition of cholesterol esterase to detect only unesterified cholesterol. In the following, all data reported for cholesterol represent unesterified cholesterol. The purity of the fractions was tested by immunoblotting using antibodies against endosomal and mitochondrial markers, as indicated.
Immunoisolation of mitochondria from murine brain.
Wildtype (Npc1 +/+ ) and NPC1-deficient (Npc1 -/-) mice were taken from an in-house breeding colony of BALB/cNctr-Npcm1N/J mice (Jackson Lab, stock number 003092). Animals were genotyped by PCR as described 41 . All procedures were approved by the Dalhousie University Committee on Laboratory Animals (protocol 08-006). For isolation of mitochondria, cerebellum, cortex and hippocampus dissected from 8 week-old Npc1 +/+ and Npc1 -/mice were homogenized in MI buffer and centrifuged at 800 g to remove cell debris. The supernatants were centrifuged for 15 min, 4°C at 14,000 g.
The pellet fraction was overlaid on a Percoll gradient constructed of 8.5 ml 30% Percoll in gradient buffer at 95,000 g, 4°C in a swing out rotor 16 . Mitochondria (100 µg) were incubated with 4 µg rabbit anti-Tom20 antibodies or unspecific control antibodies (rabbit anti-flag, Sigma F7425) in 800 µl MI buffer at 4°C overnight. Samples were centrifuged at 14,000 g for 20 min at 4°C, the resulting pellets of mitochondria decorated with antibodies were washed, resuspended in 300 µl MI buffer and incubated at 4°C overnight in a total volume of 1 ml with 10 7 Dynabeads M-500 Subcellular (coated with secondary anti-rabbit antibodies according to manufacturer's protocol). Beads were washed in MI buffer, and transferred to a fresh tube prior to elution of bound material (pure mitochondria) into PBS with 0.1% SDS. Cholesterol and protein were measured as above.
Results
Measurement of cholesterol transported to the mitochondrial inner membrane by its conversion to pregnenolone
To measure cholesterol transport to the mitochondrial inner membrane, we used the conversion of cholesterol to pregnenolone by the P450 side chain cleavage enzyme (CYP11A1). Traditional radiotracer or fluorescent imaging techniques are unsuitable to monitor cholesterol trafficking into mitochondria due to the low levels of mitochondrial cholesterol. Since pregnenolone is only formed by CYP11A1, at a rate determined by availability of cholesterol substrate at the mitochondrial inner membrane, pregnenolone production reflects cholesterol transport to the mitochondrial inner membrane 42, 43 . This approach has previously been used to investigate the role of StAR in steroid synthesis 35, 36 . We introduced CYP11A1 activity into CHO cells using an expression vector encoding a fusion protein (F2-protein) of CYP11A1, ferredoxin reductase and ferredoxin-1 with the CYP11A1 mitochondrial targeting sequence 35, 36 .
Immunostaining of CHO cells transiently transfected with the F2-fusion protein using antibodies against ferredoxin reductase yielded a distinctly mitochondrial fluorescence pattern ( Fig 1A) , which colocalized with mitotracker ( Fig 1B) , whereas untransfected cells showed little fluorescence from anti-ferredoxin reductase immunostaining. Thus, the F2-fusion protein is correctly targeted to mitochondria even when highly overexpressed.
We verified that enzymatic activity of CYP11A1 was restricted to mitochondria by subcellular fractionation and an in vitro enzyme activity assay 37 , using monoclonal CHO cell lines stably expressing the F2-fusion protein (F2-CHO). Mitochondria isolated from F2-CHO cells, but not mitochondria from parental CHO cells, produced pregnenolone from the membrane-permeable precursor 22-OH-Chol ( Fig   1C) . No significant pregnenolone formation was observed in the cell fraction remaining after removal of mitochondria ( Fig 1C) , showing that pregnenolone in F2-cells is made in mitochondria. Due to the high sensitivity of the pregnenolone radioimmunoassay and the elimination of the need for subcellular fractionation, even the low levels of basal cholesterol transport to the mitochondrial inner membrane could be measured.
Cholesterol is transported to the mitochondrial inner membrane in the absence of functional NPC1
To investigate the role of NPC1 in mitochondrial cholesterol import, we generated monoclonal wildtype (F2-CHO) or NPC1-deficient (F2-4-4-19) cell lines stably transfected with the F2-protein. We selected two clones each of wildtype F2-CHO and NPC1-deficient F2-4-4-19 cells with comparable, moderate F2-complex mRNA expression and CYP11A1 enzyme activity in lysed cells (Fig 2A and B) .
To prevent general effects on cholesterol homeostasis, we avoided clones with very high F2-complex expression. Filipin staining of endosomal cholesterol remained unaltered in F2-clones ( Fig 2C) .
Pregnenolone formation was similar in F2-CHO and F2-4-4-19 clones during 6 or 24 h, indicating that under these conditions the amount of cholesterol reaching the mitochondrial inner membrane was unchanged by NPC1-deficiency ( Fig 2D) . Addition of 22-OH-Chol increased pregnenolone production in all cell lines to a similar extent and at least 10-fold ( Fig 2E) . As a membrane-permeable precursor for CYP11A1-catalyzed pregnenolone formation, 22-OH-Chol does not rely on active transport to reach the mitochondrial inner membrane 44 ; therefore the amount of pregnenolone found in the medium of cells treated with an excess of 22-OH-Chol reflects maximum CYP11A1 activity. These results confirmed that that pregnenolone formation is not limited by the rate of cholesterol oxidation but determined by cholesterol at the mitochondrial inner membrane.
A caveat of using two separate cell lines (CHO and 4-4-19) to investigate the role of NPC1 is that slight differences in expression levels of the F2-fusion protein, a divergence of CHO and 4-4-19 cell lines, or residual function of the mutated NPC1 protein in the 4-4-19 background might have enabled mitochondrial cholesterol import in the absence of functional NPC1. We therefore used RNA interference to suppress NPC1 expression in F2-CHO. The siRNA-mediated reduction of NPC1 protein levels by nearly 95% (Fig 3A) was sufficient to induce the characteristic intracellular cholesterol accumulation within three days (Fig 3B and C) . In spite of the endosomal sequestration of cholesterol, depletion of NPC1 in F2-CHO cells had no effect on pregnenolone formation (Fig 3D) , indicating that normal levels of cholesterol reached the mitochondrial inner membrane in the absence of NPC1.
Endosomal and endogenously-synthesized cholesterol are transported to the mitochondrial inner membrane
It is commonly assumed that in NPC1-deficiency, cholesterol egress from the endosome is severely impaired, which might suggest that cholesterol transported to the mitochondrial inner membrane did not come from endosomes. However, it has also been postulated that excessive transport of accumulated endosomal cholesterol leads to increased mitochondrial cholesterol in NPC1-deficient cells 16, 23 . In the absence of suitable radiotracer techniques to monitor the low levels of mitochondrial cholesterol import, it is difficult to directly follow the trafficking of separate cholesterol pools. Thus, to investigate potential cholesterol transport pathways from endosomes to mitochondria, we induced changes in the relative abundance of endogenously-synthesized and endosomal cholesterol by incubating F2-CHO and F2-4-4-19 cells in the presence or absence of low-density lipoproteins (LDL). Pregnenolone formation and cholesterol biosynthesis were then measured during an ensuing period of acute cholesterol deprivation (serum-free medium) or re-feeding (serum-free medium with LDL).
In F2-CHO cells, pregnenolone formation was the same during a 24 h incubation in serum-free medium without exogenous cholesterol as in medium with LDL following growth in the presence of LDL ( Fig 4A) . Cholesterol biosynthesis was upregulated 5.5-fold by cholesterol deprivation under the same conditions ( Fig 4B) , indicating that depending on availability, either endocytosed or endogenouslysynthesized cholesterol were transported to the mitochondrial inner membrane. When cells were first deprived of cholesterol for 48 h in LPDS medium, and then incubated in the presence of LDL for 24 h (LDL "re-feeding"), cholesterol biosynthesis was downregulated nearly 7-fold in F2-CHO cells. During the same time period of re-feeding, we observed a 30% increase of pregnenolone formation, suggesting that LDL-derived endosomal cholesterol moved to the mitochondrial inner membrane.
In NPC1-deficiency, most egress of cholesterol from endosomes is impaired. To test whether this is also the case for the movement of endosomal cholesterol to mitochondria, we performed the same cholesterol deprivation and re-feeding experiments in F2-4-4-19 cells (Fig 4C and D) . Cholesterol biosynthesis in F2-4-4-19 cells incubated in the presence of LDL was lower than in F2-CHO cells under the same conditions, and was upregulated to a much lesser extent during a 24 h cholesterol deprivation period than in F2-CHO cells ( Fig 4D) . Still, F2-4-4-19 cells produced the same amount of pregnenolone in the absence or presence of LDL ( Fig 4C) and also produced as much pregnenolone as F2-CHO cells cells. Moreover, following a 48 h period of cholesterol deprivation, F2-4-4-19 cells responded to LDL-refeeding with a 30% increase in pregnenolone formation compared to cells in the continued absence of LDL ( Fig 4C) . This response of cholesterol-depleted F2-4-4-19 cells to addition of LDL was comparable to the response of F2-CHO cells. Since, as demonstrated in Fig 2B, the maximal catalytic activity of the F2-fusion protein by far exceeded the rates of pregnenolone formation under basal conditions, we assume that neither in F2-CHO nor in F2-4-4-19 cells the increase in cholesterol transport to the mitochondrial inner membrane was greater than detected in our assay. Arrival at the mitochondrial outer membrane alone would, however, not be detected by the F2 complex. These observations strongly suggest, that endosomal cholesterol was transported to the mitochondrial inner membrane in the absence of functional NPC1. However, cholesterol depletion for 48 h had the unexpected effect that pregnenolone formation in 
F2-CHO, but not F2-4-4-19 cells, was increased compared to cells preincubated in the presence of LDL
prior to the measurement period.
MLN64 mediates transport of cholesterol to mitochondria
A prime candidate for mediating cholesterol trafficking from endosomes to mitochondria is MLN64, which resides in the same endosomal population as NPC1, and has a cholesterol-binding START domain on the cytosolic side 28 . To test whether MLN64 contributes to mitochondrial cholesterol import, we transfected F2-CHO cells with siRNA directed against MLN64 either alone or together with siRNA against NPC1. MLN64 and NPC1 protein levels were reduced by 80 -90 % as shown by immunoblotting ( Fig 5A) . MLN64-depletion by two different siRNA sequences caused a significant decrease in pregnenolone formation in cholesterol-fed cells either alone or in combination with siRNAmediated depletion of NPC1 ( Fig 5B) . To test whether MLN64 mediates transport of LDL-derived cholesterol, we measured pregnenolone formation during re-feeding of LDL to cholesterol-deprived cells.
RNA interference against MLN64 or against both MLN64 and NPC1 caused a 30% reduction of pregnenolone formation under these conditions ( Fig 5C) , which was similar to the increase in pregnenolone formation that we observed in cells given LDL following cholesterol deprivation compared to cells in the continued absence of LDL (Fig 4) . Pregnenolone formation was never completely inhibited by MLN64 depletion, indicating that, as expected, MLN64 is not the only pathway for mitochondrial cholesterol import.
Mitochondrial cholesterol content is increased in NPC1-deficient cells
Several studies have reported increased mitochondrial cholesterol content in NPC1-deficient cells or tissue. We found a similar increase in cholesterol in the mitochondrial fraction isolated by density gradient ultracentrifugation of lysed CHO and 4-4-19 cells and in mitochondria further purified by immunoisolation with antibody-coated magnetic beads ( Fig 6A) . Due to species reactivity of the antibody and the large amount of material required, these mitochondria were isolated from wildtype and NPC1deficient murine brain. The purity of fractions was verified by immunoblotting against endosomal and mitochondrial markers ( Fig 6B) . However, our observation of MLN64-mediated transport of cholesterol from endosomes to mitochondria suggests the existence of sites of close contact between endosomes and mitochondria, since the N-terminal domain of MLN64 is anchored in the endosomal perimeter membrane, and the C-terminal START domain likely needs to come in contact with the mitochondrial outer membrane if direct cholesterol transfer takes place 27 . If parts of endosomes were attached to mitochondria, even a thorough isolation of mitochondria by density fractionation or immunoisolation would co-purify some endosomal membranes. To test whether this is the explanation for the reported increase in mitochondrial cholesterol, we disrupted potential protein-mediated contact sites by mild trypsin treatment of the crude mitochondria fraction containing mitochondria and endosomes/lysosomes, and separated the trypsinized fraction by density ultracentrifugation. Trypsin treatment did not markedly affect mitochondrial ultrastructure ( Fig 6C) , nor did it change sedimentation in the Percoll gradient (not shown). Endosomal LAMP1 and the mitochondrial outer membrane protein VDAC were partially degraded by trypsin treatment, as shown by the presence of lower molecular weight bands in the immunoblot, whereas cytochrome c oxidase in the mitochondrial inner membrane remained intact ( Fig   6D) . For unknown reasons, trypsin degradation of VDAC seemed stronger in the 4-4-19 derived fractions.
Immunoblotting with an antibody against the cytosolic domain of MLN64 did not detect any bands in trypsinized endosomes or mitochondria ( Fig 6D) . We therefore conclude that protein contact sites were disrupted. Indeed, Percoll density ultracentrifugation following mild trypsinization yielded a mitochondrial fraction free of endosomal proteins in the immunoblot (Fig 6D) . Some VDAC was detected in the endosome-enriched upper band of the density gradient, indicating that the mitochondria isolation was not quantitative (Fig 6D) . Importantly, cholesterol levels were increased in mitochondrial fractions from NPC1-deficient 4-4-19 compared to wildtype CHO cells even after artificial disruption of potential contact sites (Fig 6E) , strongly indicating that cholesterol builds up in the mitochondrial membranes, and is not merely a contamination with endosomes. Further support for this conclusion comes from the observation that imipramine treatment, which is known to cause endosomal cholesterol accumulation, did not lead to increased cholesterol in mitochondrial fractions ( Fig 6E) .
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Since the arrival of cholesterol at the mitochondrial inner membrane was not increased in NPC1deficient cells (Fig 2 and 3) , these data suggest that cholesterol transport from the outer to the inner membrane becomes rate-limiting under certain conditions. Interestingly, imipramine significantly increased cholesterol transport to the mitochondrial inner membrane by 44% ± 2.8 % (not shown) compared to untreated CHO cells, which might suggest that in this case, cholesterol build-up was prevented by increased movement from mitochondrial outer to inner membrane.
Depletion of MLN64 reduces mitochondrial cholesterol build-up in NPC1-deficient cells
If cholesterol building up in mitochondria of NPC1-deficient cells was transported by MLN64 from the endosomes, suppression of MLN64 expression should decrease mitochondrial cholesterol. As expected, reduction of MLN64 protein levels in CHO and 4-4-19 cells by RNA interference (Fig 7A) significantly decreased mitochondrial cholesterol levels in 4-4-19 cells compared to 4-4-19 cells transfected with non-targeting siRNA ( Fig 7B) . In CHO cells, MLN64 depletion had no effect on cholesterol content of either mitochondrial or endosomal/lysosomal fractions. For unknown reasons, siRNA-transfected cells had higher mitochondrial cholesterol levels than non-transfected cells regardless of siRNA sequence. Cholesterol content of the endosome-enriched fraction was markedly increased in 4- (Fig 7C) , suggesting that only a small percentage of accumulated cholesterol is transported out of the endosome by MLN64. This observation also speaks for the purity of the isolated mitochondrial fraction, since a contamination with lysosomal cholesterol would have masked the small reduction in the absolute amount of cholesterol in the mitochondrial fraction of MLN64-depleted 4-4-19 cells.
4-19 cells compared to CHO cells, but not affected by MLN64 depletion
Discussion
Alterations in cholesterol metabolism have been observed in several neurodegenerative disorders but the mechanisms connecting defects of cholesterol metabolism to cellular dysfunction are not clear.
One hypothesis is that alterations in mitochondrial cholesterol homeostasis could negatively affect mitochondrial and cellular function. In NPC disease, loss of NPC1 function leads to accumulation of cholesterol in late endosomes/lysosomes and an impaired cholesterol homeostatic response, which could affect mitochondrial cholesterol trafficking. Here we show that cholesterol is transported to the mitochondrial inner membrane in the absence of functional NPC1, and provide evidence that MLN64 contributes to cholesterol transport to mitochondria, likely using endosomal cholesterol. Our data suggest that in NPC1-deficient cells, cholesterol builds up in mitochondria due to increased cholesterol transfer to the mitochondrial outer membrane by MLN64 while transfer of cholesterol from the mitochondrial outer to inner membrane becomes rate-limiting.
Using an assay measuring cholesterol transport to the mitochondrial inner membrane by following its conversion to pregnenolone, we found similar levels of cholesterol transported to the mitochondrial inner membrane in NPC1-defective F2-4-4-19 cells and in F2-CHO cells with siRNA-mediated depletion of NPC1, compared to control F2-CHO cells (Fig 2 and 3) . These data show that NPC1 was not required for basal cholesterol import into mitochondria, or that alternative pathways were upregulated in the absence of NPC1. Pregnenolone formation was normal in F2-4-4-19 cells even at the 6 h time point, suggesting that cholesterol movement to the mitochondrial inner membrane was not, or was only slightly, delayed in the absence of NPC1 ( Fig 2D) . Cholesterol transport to the mitochondrial inner membrane remained relatively constant in both F2-CHO and F2-4-4-19 cells under conditions of different availability of cholesterol from synthesis and endocytosis ( Fig 4A and C) , indicating that both endosomal and endogenously-synthesized cholesterol can enter mitochondria. Thus, during prolonged cholesterol deprivation, endogenous synthesis could provide mitochondria with the necessary cholesterol, whereas additional cholesterol reaching the mitochondrial inner membrane during re-feeding LDL to cholesteroldeprived cells most likely represented transport of LDL-derived, endosomal cholesterol. The observed increase in cholesterol import into mitochondria in response to LDL is in line with the known stimulation of oxysterol production by lipoproteins 45 . Oxysterols play an important role in the regulation of sterol metabolism and are formed in part by 27-cholesterol hydroxylase at the mitochondrial inner membrane 46, 47 . In NPC1-deficient fibroblasts and macrophages, oxysterol production during a 24 h time period in the presence of LDL following a 48 h cholesterol deprivation was lower than in wildtype cells 22, 45 . Under the same conditions, pregnenolone formation by F2-4-4-19 cells appeared lower than in F2-CHO cells. However, it became evident that while the basal pregnenolone production in LPDScontaining medium without lipoproteins was lower in F2-4-4-19 cells than in F2-CHO cells, the increase in pregnenolone formation due to addition of LDL was similar, suggesting that transport of LDL-derived endosomal cholesterol to the mitochondrial inner membrane was not impaired in the absence of NPC1 function. The decrease in pregnenolone formation in serum-starved F2-4-4-19 compared to serum-starved F2-CHO cells might be due to comparatively lower rates of cholesterol biosynthesis in F2-4-4 19 cells under these conditions, or to a defect in another cholesterol trafficking pathway that mediates mitochondrial cholesterol import when only little endosomal cholesterol is available.
These experiments clearly indicated that there are several pathways transporting cholesterol to the mitochondrial membranes, one of them using endosomal cholesterol. A likely candidate for cholesterol transport from endosomes to mitochondria is MLN64, a late endosomal transmembrane protein with a cholesterol-binding START domain on the cytosolic side 28 . Expression of N-218 MLN64, an Ntruncated, soluble construct of MLN64 containing the START domain, increased cholesterol delivery for mitochondrial steroidogenesis in a mechanism similar to StAR 29, 48, 30, 49, 50 . However, it had not been clear whether full-length MLN64 contributed to basal mitochondrial cholesterol import. Our observation that depletion of MLN64 by RNA interference reduces cholesterol transport to the mitochondrial inner membrane by 30 -40% depending on culture conditions (Fig 5) , clearly demonstrates that MLN64 plays a significant role in mitochondrial cholesterol homeostasis. The extent to which LDL re-feeding increased pregnenolone production in F2-CHO and F2-4-4-19 cells (Fig 4) agreed well with the extent of inhibition of pregnenolone formation caused by MLN64 depletion under re-feeding conditions in F2-CHO cells, and in F2-CHO cells transfected with siRNA against NPC1 ( Fig 5C) . The comparison of these data suggests that most LDL-derived cholesterol reaching the mitochondrial inner membrane was transported via MLN64. On the other hand, RNA interference against MLN64 also revealed a remarkable redundancy of cholesterol trafficking pathways into mitochondria, in line with the relatively constant pregnenolone formation under different states of cholesterol homeostasis (Fig 4) . A large part of cholesterol transported independently of MLN64 is likely to be endogenously-synthesized cholesterol. In addition, a recent study described cholesterol transport from plasma membrane to mitochondria 26 . This latter pathway would require cytosolic sterol carrier proteins 51 , such as sterol carrier protein 2, or other START proteins such as StARD4 or StARD5, which have both been shown to bind cholesterol 52, 53 . Overexpression of StARD4
(but not StARD5) in hepatocytes increased cholesterol ester synthesis in the endoplasmic reticulum as well as bile acid formation in mitochondria 53 . The redundancy of pathways to maintain mitochondrial cholesterol homeostasis could explain reports that mice with a targeted deletion of the MLN64 START domain developed only minor phenotypic defects 54 .
The relatively constant rates of pregnenolone formation under conditions of widely different cholesterol homeostasis not only suggest the presence of several pathways for cholesterol transport into mitochondria, but also that these pathways might be largely dependent on the availability of cholesterol from different sources. If MLN64-dependent transport was mainly regulated by the amount of endosomal cholesterol, this would be in line with the build-up of cholesterol in mitochondrial fractions from NPC1deficient cells and tissues that has been reported previously 16, 23 , and that we observed in 4-4-19 cells ( Fig   6A) . However, mitochondria isolated by density gradient centrifugation may be contaminated by small amounts of endosomes, in particular when endosomal density is altered by NPC1-deficiency. Moreover, since MLN64, in analogy to StAR, likely needs direct contact with mitochondria for cholesterol transfer, endosome-mitochondria contact sites would be required unless MLN64 is cleaved. We therefore took several different approaches to purify mitochondria, including immunoisolation, which does not rely on organellar density, and trypsinization of crude mitochondria to disrupt potential contact sites prior to density gradient centrifugation. Under all conditions, mitochondrial fractions from NPC1-deficient cells had higher levels of cholesterol per protein than wildtype ( Fig 6) . Moreover, in imipramine treated cells, endosomal but not mitochondrial cholesterol was increased compared to control, underlining the purity of the mitochondrial fraction ( Fig 6E) . Together, these data strongly suggest that cholesterol builds up in mitochondrial membranes of NPC1-deficient cells, but direct proof would require cholesterol quantification on the ultrastructural level.
Since we did not observe an increase in cholesterol reaching CYP11A1 at the inner membrane in NPC1-deficient 4-4-19 cells (Fig 2 and 3) , our data suggest a model whereby MLN64 transfers endosomal cholesterol to the mitochondrial outer membrane and where cholesterol transfer from mitochondrial outer to inner membrane may become rate-limiting. This model is supported by our finding of a significant reduction of mitochondrial cholesterol accumulation in 4-4-19 cells after siRNA-mediated depletion of MLN64. Mitochondrial cholesterol was not completely normalized by MLN64 depletion, which could be due to incomplete turnover of mitochondrial cholesterol during siRNA transfection, but would also be in line with increased cholesterol transport by additional proteins. Further investigations are required to determine the relative contributions of different transport mechanisms for different conditions and cell types.
In summary, this study defines a transport pathway from endosomes to mitochondria that requires MLN64 but not NPC1. Endosomal cholesterol accumulation in NPC1-deficiency leads to increased MLN64-mediated transport of cholesterol to mitochondria and a build-up of cholesterol in the mitochondrial outer membrane. Since increased mitochondrial cholesterol is potentially detrimental for mitochondrial function, MLN64-mediated cholesterol transport might present a target for future attempts to correct mitochondrial cholesterol homeostasis and mitochondrial function. 
